Cargando…

Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes, and retinal microaneurysms (MA) are one of the first detected abnormalities associated with DR. We recently showed elevated serum triglyceride levels to be associated with the development of MA in the Finnish Diabet...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mello, Vanessa Derenji, Selander, Tuomas, Lindström, Jaana, Tuomilehto, Jaakko, Uusitupa, Matti, Kaarniranta, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703764/ https://www.ncbi.nlm.nih.gov/pubmed/34960007 http://dx.doi.org/10.3390/nu13124452

Ejemplares similares

Longitudinal Branched-Chain Amino Acids, Lifestyle Intervention, and Type 2 Diabetes in the Finnish Diabetes Prevention Study
por: Kivelä, Jemina, et al.
Publicado: (2022)

Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
por: Sehgal, Ratika, et al.
Publicado: (2022)

Life Style Intervention Improves Retinopathy Status—The Finnish Diabetes Prevention Study
por: Aro, A., et al.
Publicado: (2019)

Leukocyte Telomere Length in the Finnish Diabetes Prevention Study
por: Hovatta, Iiris, et al.
Publicado: (2012)

Insulin Secretion and Its Determinants in the Progression of Impaired Glucose Tolerance to Type 2 Diabetes in Impaired Glucose-Tolerant Individuals: The Finnish Diabetes Prevention Study
por: de Mello, Vanessa D.F., et al.
Publicado: (2012)

Eating behavior dimensions and 9-year weight loss maintenance: a sub-study of the Finnish Diabetes prevention study
por: Salmela, Jutta, et al.
Publicado: (2023)

Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial
por: Uusitupa, Matti, et al.
Publicado: (2009)

Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond
por: Tuomilehto, Jaakko, et al.
Publicado: (2023)

Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals
por: Tuomainen, Marjo, et al.
Publicado: (2018)

Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study
por: de Mello, Vanessa D., et al.
Publicado: (2017)

Sleep Duration, Lifestyle Intervention, and Incidence of Type 2 Diabetes in Impaired Glucose Tolerance: The Finnish Diabetes Prevention Study
por: Tuomilehto, Henri, et al.
Publicado: (2009)

Impact of Positive Family History and Genetic Risk Variants on the Incidence of Diabetes: The Finnish Diabetes Prevention Study
por: Uusitupa, Matti I., et al.
Publicado: (2011)

Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study
por: Siitonen, Niina, et al.
Publicado: (2011)

Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study
por: Siitonen, Niina, et al.
Publicado: (2011)

Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: The Finnish Diabetes Prevention Study
por: Salopuro, Titta, et al.
Publicado: (2009)

Leisure-Time Physical Activity and the Metabolic Syndrome in the Finnish Diabetes Prevention Study
por: Ilanne-Parikka, Pirjo, et al.
Publicado: (2010)

Variations in the Ghrelin Receptor Gene Associate with Obesity and Glucose Metabolism in Individuals with Impaired Glucose Tolerance
por: Mager, Ursula, et al.
Publicado: (2008)

The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
por: Lind, Marcus, et al.
Publicado: (2014)

Involvement of Plasmalogens in Post-Natal Retinal Vascular Development
por: Saab, Sarah, et al.
Publicado: (2014)

Dietary plasmalogen increases erythrocyte membrane plasmalogen in rats
por: Mawatari, Shiro, et al.
Publicado: (2012)

Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention: Time to expand the efforts
por: Tuomilehto, Jaakko, et al.
Publicado: (2011)

Validation of the cough phenotype TBQ among elderly Finnish subjects
por: Koskela, Heikki O., et al.
Publicado: (2022)

Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)—A Randomized Controlled Lifestyle Trial †
por: Ngandu, Tiia, et al.
Publicado: (2014)

Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care: One-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D)
por: Saaristo, Timo, et al.
Publicado: (2010)

Plasmalogen Replacement Therapy
por: Bozelli, José Carlos, et al.
Publicado: (2021)

Plasmalogen biosynthesis is spatiotemporally regulated by sensing plasmalogens in the inner leaflet of plasma membranes
por: Honsho, Masanori, et al.
Publicado: (2017)

Satisfaction of young ENT surgeons with their work. A Finnish national study
por: Penttilä, Elina, et al.
Publicado: (2021)

Ocular surface health of the Finnish elderly population
por: Aapola, Ulla, et al.
Publicado: (2022)

Adverse perinatal outcomes among practical nurses: The Finnish Medical Birth Register Study
por: Kwegyir-Afful, Emma, et al.
Publicado: (2021)

Plasmalogens and Chronic Inflammatory Diseases
por: Bozelli, José Carlos, et al.
Publicado: (2021)

Plasmalogens in bacteria, sixty years on
por: Goldfine, Howard
Publicado: (2022)

Glycerol and Fatty Acids in Serum Predict the Development of Hyperglycemia and Type 2 Diabetes in Finnish Men
por: Mahendran, Yuvaraj, et al.
Publicado: (2013)

Cross-cultural adaptation and validation of the Finnish version of the central sensitization inventory and its relationship with dizziness and postural control
por: Mikkonen, Jani, et al.
Publicado: (2021)

Time-Dependent Analysis of Plasmalogens in the Hippocampus of an Alzheimer’s Disease Mouse Model: A Role of Ethanolamine Plasmalogen
por: Azad, Abul Kalam, et al.
Publicado: (2021)

C-peptide and Retinal Microangiopathy in Diabetes
por: Chakrabarti, Subrata, et al.
Publicado: (2004)

Plasmalogens and Alzheimer’s disease: a review
por: Su, Xiao Q., et al.
Publicado: (2019)

Lymphatic Absorption of Microbial Plasmalogens in Rats
por: Sato, Nana, et al.
Publicado: (2022)

Plasmalogen Biosynthesis by Anaerobic Bacteria: Identification of a Two-Gene Operon Responsible for Plasmalogen Production in Clostridium perfringens
por: Jackson, David R., et al.
Publicado: (2020)

Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons
por: Goodenowe, Dayan B., et al.
Publicado: (2022)

Cross-Cultural Adaptation, Reliability, and Psychophysical Validation of the Pain and Sleep Questionnaire Three-Item Index in Finnish
por: Mikkonen, Jani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lhlr3cohmj5s3inlfgde16hkvt